No Data
No Data
Relay Therapeutics Says RLY-2608 With Fulvestrant Data Shows 'Clinically Meaninful' Metastatic Breast Cancer Survival
Express News | Relay Therapeutics Shares up 7.5% Premarket After Co Reports Interim Data for Breast Cancer Drug
Express News | Relay Therapeutics Inc -Data Support Planned Initiation of 2L Pivotal Study in 2025
Express News | Relay Therapeutics Inc: 39% Confirmed Orr Across All Patients & 67% in Patients With Kinase Mutations at Rp2D
Relay Therapeutics Announces Updated Interim Data for RLY-2608 + Fulvestrant Demonstrating Continued Maturation of Clinically Meaningful Progression Free Survival
Express News | Relay Therapeutics Announces Updated Interim Data for Rly-2608 + Fulvestrant Demonstrating Continued Maturation of Clinically Meaningful Progression Free Survival
Unlock the Full List
Trytosaveabit : How’s that sleep going? Hehehe
Jaguar8 OP Trytosaveabit : Only had 30minutes
Trytosaveabit Jaguar8 OP : Grrr!
Jaguar8 OP Trytosaveabit : I think I’ll sleep again
Trytosaveabit Jaguar8 OP : Ok!